Lilly’s weight loss drug reduces diabetes risk in overweight patients
Eli Lilly’s weight-loss drug Zepbound dramatically reduces the risk of developing type 2 diabetes in overweight or obese pre-diabetic adults after three years of weekly injections, the drug’s maker said Tuesday.
ПОПУЛЯРНЫЕ ПОСТЫ
Colombia was the deadliest country for environmentalists in 2023
Сентябрь 11, 2024
Floods inundate northern Vietnam, Typhoon Yagi death toll rises
Сентябрь 11, 2024
Destin Daniel Cretton in talks to direct ‘Spider-Man 4’
Сентябрь 11, 2024
ПОДПИСЫВАЙТЕСЬ НА НАС
ПРЯМАЯ ТРАНСЛЯЦИЯ